U.S. doesn't have funds to buy a 4th vaccine dose for everyone if needed, officials warn


The U.S. does not have enough funding to purchase a fourth COVID vaccine dose for every American should the shots be deemed necessary, The Washington Post reports Tuesday, per Biden administration officials.
Though the White House has enough doses to cover a fourth shot for Americans over age 65, as well as the initial recommended regimen for kids under 5, "officials say they cannot place advance orders for additional vaccine doses for those in other age groups, unless lawmakers pass a stalled $15 billion funding package," the Post writes.
"Right now, we don't have enough money for fourth doses, if they're called for," White House COVID response coordinator Jeff Zients told Andy Slavitt on an upcoming podcast episode, per the Post. "We don't have the funding, if we were to need a variant-specific vaccine in the future."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It has yet to be determined whether a fourth dose will even be needed, but officials warned they'd need to move preemptively if that were the case, rather than wait until the time comes. For that to happen, the funding from Congress is required.
"Vaccines don't just appear when you snap your fingers and say, 'Okay, I want the vaccine.' We've got to make it," said one senior official.
"If their policy goal is to have enough doses available to provide a fourth dose to everyone," confirmed Jen Kates of the nonpartisan Kaiser Family Foundation, "there are not enough doses purchased. They will run out of supply." She said the administration would need to purchase approximately 750 million more doses to cover all Americans.
Officials are also concerned vaccine manufacturers will prioritize orders already in the pipeline from other countries, thus delaying shipments to the U.S., per the Post. Read more at The Washington Post.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
White House joins GOP speech policing, citing Kirk
Speed Read Yesterday’s developments ‘underscore the extraordinary amount of time and resources’ the White House has dedicated to advancing Kirk’s legacy
-
House posts lewd Epstein note attributed to Trump
Speed Read The estate of Jeffrey Epstein turned over the infamous 2003 birthday note from President Donald Trump
-
Supreme Court allows 'roving' race-tied ICE raids
Speed Read The court paused a federal judge's order barring agents from detaining suspected undocumented immigrants in LA based on race
-
South Korea to fetch workers detained in Georgia raid
Speed Read More than 300 South Korean workers detained in an immigration raid at a Hyundai plant will be released
-
Why are Trump's health rumors about more than just presidential fitness?
TODAY'S BIG QUESTION Extended absences and unexplained bruises have raised concerns about both his well-being and his administration's transparency
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mount
Speed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers